# Effects of Ranibizumab in Primary Pterygium Surgery

> **NCT04878835** · PHASE1 · COMPLETED · sponsor: **Universiti Sains Malaysia** · enrollment: 52 (actual)

## Conditions studied

- Patients With Primary Nasal Pterygium

## Interventions

- **BIOLOGICAL:** intralesional ranibizumab

## Key facts

- **NCT ID:** NCT04878835
- **Lead sponsor:** Universiti Sains Malaysia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-04-30
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2021-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04878835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04878835, "Effects of Ranibizumab in Primary Pterygium Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04878835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*